The Oklahoma Shared Clinical and Translational Resources

The OSCTR is funded by the National Institutes of Health as part of its IDeA-CTR program. We have the mission to serve as a catalyst for clinical and translational research that improves health and healthcare for Oklahomans, to provide training and infrastructure to help junior investigators to launch independent research careers, and to expand the opportunities of IDeA states and Oklahoma communities to participate in research that improves the health of our residents. 

Oklahoma Clinical and Translational Science Institute

 

OCTSI is the home of the OSCTR, as well as clinical research services and dissemination and implementation resources to help improve the delivery of healthcare. 

Oklahoma Primary Healthcare Improvement Cooperative

 

OPHIC is the implementation science arm of a statewide network to help improve healthcare delivery assisting primary care practices to adopt evidence-based best practices for the care of their patients.

OCTSI Clinical Research Unit

​​

The OCTSI CRU assists medical providers to identify and conduct clinical research opportunities in Oklahoma.

2026 REDCapCon

Calling all REDCap professionals! We're excited to announce 2026 REDCapCon!

REDCapCon, an annual REDCap conference, is a three and a half-day event which offers educational and networking opportunities to REDCap administrators around the world! REDCap administrators perform a variety of functions at their institutions including technical support of the installations, end user training and support, account management, and institutional marketing of REDCap.

Oklahoma Health Services Research Conference Coming This Fall

On behalf of the OCTSI and the Department of Medicine, we are pleased to announce the inaugural Oklahoma Health Services Research Conference! This event will showcase national leaders in health services research from outside institutions and across the University of Oklahoma Health Campus. This event is open to all faculty and trainees from all Colleges.

SAVE THE DATE: Tuesday, October 27, 2026 from 7:30 am to 4:30 pm at the Nicholson Tower 5th floor conference center – 1000 NE 13th St., Oklahoma City, OK 73104.

OSCTR Pilot Program 2026

The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical and Translational Resources (OSCTR) is soliciting applications for its Clinical and Translational Research Pilot (CTRP) Grants Program.

Purpose

Subscribe to News

Recent Publications

Characterizing the Burden of Tobacco-Associated Cancers in Oklahoma: A Demographic and Geographic Perspective, 2018-2022

J Okla State Med Assoc. 2026 Mar-Apr;119(2):48-55.

ABSTRACT

BACKGROUND: Despite declining national smoking rates, Oklahoma continues to experience high tobacco use, particularly among groups such as American Indian/Alaska Native (AI/AN) and rural populations. Cigarette smoking is a leading cause of cancer, and tobacco-related cancer incidence remains a significant public health concern in Oklahoma.

The Burden of Obesity-Related Cancers in Oklahoma: Trends, Demographics, and Spatial Patterns

J Okla State Med Assoc. 2026 Jan-Feb;119(1):7-16.

ABSTRACT

BACKGROUND: Obesity is a growing public health crisis in the United States, with over 70% of adults classified as overweight or obese. It has been associated with multiple health conditions, including at least 13 types of cancer. Despite this, awareness of the obesity-cancer link remains low, with only 53% of Americans aware of it as of 2019. Understanding the epidemiology of obesity-related cancers is critical, particularly in high-obesity states like Oklahoma.

Discrimination experiences are associated with same-day and next-day smoking among adults with low socio-economic status trying to quit: A secondary analysis of data from a randomized clinical trial

Addiction. 2026 Apr 30. doi: 10.1111/add.70419. Online ahead of print.

ABSTRACT

BACKGROUND AND AIMS: Research indicates that experiencing discrimination may be associated with a return to smoking following a quit attempt. The current study aimed to characterize day-to-day relations between discrimination and smoking in the context of a smoking cessation trial for adults with socio-economic disadvantage.

HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative

Open Forum Infect Dis. 2026 Jan 15;13(1):ofaf731. doi: 10.1093/ofid/ofaf731. eCollection 2026 Jan.

ABSTRACT

BACKGROUND: While disparities in COVID-19 therapeutic access have been documented, the effect of HIV status on treatment access and how it intersects with other sociodemographic factors has not been well explored. Using data from the National Clinical Cohort Collaborative (N3C), we investigated disparities in COVID-19 therapeutic prescription among persons with HIV and without HIV.

Upcoming Events

Media